Androgenetic Alopecia Treatment Market Report 2026

Androgenetic Alopecia Treatment Market Overview

• Androgenetic Alopecia Treatment market size has reached to $2.44 billion in 2025 • Expected to grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: Rising Hair Loss Cases Drive Growth In The Androgenetic Alopecia Treatment Market • Market Trend: Innovative Developments In Androgenetic Alopecia Treatment With FDA Approvals And New Drug Options Lead The Way • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Androgenetic Alopecia Treatment Market?

Androgenetic alopecia, also known as male-pattern baldness or female-pattern hair loss, is a common form of hair loss in both men and women. It is characterized by a progressive thinning of the hair, typically starting with a receding hairline in men and diffuse thinning over the crown in women. This condition is influenced by genetic factors and the presence of androgens, particularly dihydrotestosterone (DHT). The main types of androgenetic alopecia treatments are pharmaceuticals and devices. A pharmaceutical is a substance utilized in healthcare, typically a medicinal drug or chemical compound. The different types of medications are prescription and over-the-counter which are used by both males and females. It is used by several end-user industries including homecare settings, dermatology, clinics, and others.

What Is The Androgenetic Alopecia Treatment Market Growth Forecast?

The androgenetic alopecia treatment market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to technological advancements in laser and device therapies, personalized and precision medicine approaches, integration of ai in hair loss diagnosis, growth in teledermatology platforms, rising demand for minimally invasive hair restoration procedures. Major trends in the forecast period include personalized hair loss treatments, minimally invasive hair restoration procedures, natural and herbal hair growth solutions, teledermatology & remote hair care consultations, combination therapy approaches.

What Is The Driver Of The Androgenetic Alopecia Treatment Market?

The rising hair loss cases are expected to propel the growth of the androgenetic alopecia treatment market going forward. Hair loss or alopecia refers to the partial or complete loss of hair from the scalp or other body parts. Hair loss cases are related to nutritional deficiencies, hormonal changes, genetics, and increased stress. Androgenetic alopecia treatments work through various mechanisms, including hormonal regulation, follicle stimulation, and surgical restoration, to manage hair loss and promote regrowth. For instance, in 2024, according to the National Health Service, a UK-based government agency, approximately 8 million women and 6.5 million men are affected by hair loss in the UK. Additionally, more than 650,000 hair transplants are carried out each year. Therefore, rising hair loss cases drive the androgenetic alopecia treatment industry.

Key Players In The Global Androgenetic Alopecia Treatment Market

Major companies operating in the androgenetic alopecia treatment market are Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Allergan Plc, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Fagron Inc., Curallux LLC, Theradome Inc., Lexington International, Apira Science Inc., Freedom Laser Therapy Inc., Follica Inc., Histogen Inc., Aclaris Therapeutics Inc., HCell Inc., Cosmo Pharmaceuticals N.V., AbbVie Inc., Daiichi Sankyo Company Limited

Global Androgenetic Alopecia Treatment Market Trends and Insights

Major companies operating in the androgenetic alopecia treatment market are developing innovative drug options for addressing hair loss through mechanisms such as promoting hair follicle regeneration, inhibiting hormones that cause hair loss, and using novel delivery systems like topical treatments and oral medications. For instance, in June 2023, Pfizer Inc., a US-based healthcare company, announced the FDA approval of LITFULO (ritlecitinib), a once-daily oral treatment for individuals 12 years of age and older with severe alopecia areata. LITFULO is a kinase inhibitor that inhibits Janus kinase 3 (JAK3) and the tyrosine kinase expressed in the hepatocellular carcinoma (TEC) family of kinases. The FDA approval was based on the ALLEGRO Phase 2b/3 trial, where 23% of patients treated with LITFULO 50mg achieved 80% or more scalp hair coverage after six months compared to 1.6% with placebo. The solution offers a new option for individuals struggling with substantial hair loss, addressing a previously unmet need to treat alopecia areata.

What Are Latest Mergers And Acquisitions In The Androgenetic Alopecia Treatment Market?

In April 2023, Marksans Pharma, an India-based pharmaceutical company, acquired the manufacturing facility from Tevapharm India for an undisclosed amount. This strategic move allowed Marksans Pharma to double its existing Indian manufacturing capacity and expand its product range to include tablets, capsules, ointments, liquids, and creamsTeva Pharmaceuticals is an Israel-based company that provides treatment for androgenetic alopecia.

What Defines the Androgenetic Alopecia Treatment Market?

The androgenetic alopecia treatment market consists of sales of microneedling devices, hair growth vitamins, and supplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Androgenetic Alopecia Treatment Market Report 2026?

The androgenetic alopecia treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the androgenetic alopecia treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.